Community Practice Connections: DIAGNOSIS AND TREATMENT OF MF AND PV: Where Are We, and Where Are We Going?

Target Audience
This educational program is directed toward medical oncologists, hematologists, and other health care professionals who treat patients with MPNs. Fellows, researchers, nurse practitioners, nurses, physician assistants, and other allied professionals interested in hematologic malignancies are also invited to attend.

Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
• Determine the impact of genetics, symptom burden, and risk stratification on therapy selection in MPNs
• Evaluate the clinical profiles of current and emerging therapeutic strategies in MPNs across lines of therapy
• Identify and manage disease-associated symptoms and treatment-related toxicities in patients with MPNs
• Translate updated clinical trial evidence and guidelines into personalized treatment plans for patients with MPNs to optimize care across the disease continuum